JSPR - Jasper Therapeutics Inc

1.38
0.010   0.725%

Share volume: 1,174,074
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.17%

PREVIOUS CLOSE
CHG
CHG%
$1.37
0.01
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 28%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.82%
1 Month
1.47%
3 Months
-22.03%
6 Months
-46.72%
1 Year
-73.86%
2 Year
-94.80%
Key data
Stock price
$1.38
P/E Ratio 
0.00
DAY RANGE
$1.35 - $1.44
EPS 
-$5.45
52 WEEK RANGE
$1.11 - $7.19
52 WEEK CHANGE
-$73.86
MARKET CAP 
39.593 M
YIELD 
N/A
SHARES OUTSTANDING 
27.984 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
3.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$457,872
AVERAGE 30 VOLUME 
$441,949
Company detail
CEO: Ronald A. Martell
Region: US
Website: www.jaspertherapeutics.com
Employees: 20
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.

Recent news